Assistant Professor, Medicine, Brigham and Women's Hospital, Harvard Medical School
Pathology
Dr. Ruben D. Carrasco, MD
|
|
Give Review
Dr. Ruben D. Carrasco is an expert in the field of Pathology. Ruben Carrasco is also published. He has 17 publications published. The lastest publication: "Multimodality imaging and clinical features in Castleman disease: single institute experience in 30 patients.' Ruben D. Carrasco accepts Medicare payments and is listed with Medicare.gov.
Publications
- Multimodality imaging and clinical features in Castleman Disease: single institute experience in 30 patients.
- Crosstalk between microRNA30a/b/c/d/e-5p and the Canonical Wnt Pathway: Implications for Multiple Myeloma therapy.
- Transcriptional repression of plasma cell differentiation is orchestrated by aberrant over-expression of the ETS factor SPIB in Waldenström macroglobulinaemia.
- A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple Myeloma and overcomes bortezomib resistance.
- Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML.
- A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple Myeloma cells and overcomes bortezomib resistance.
- Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma.
- Eph-B2/ephrin-B2 interaction plays a major role in the adhesion and proliferation of Waldenstrom's Macroglobulinemia.
- Pathogenesis of Myeloma.
- PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.
- A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple Myeloma.
- Bortezomib induces canonical nuclear factor-kappaB activation in multiple Myeloma cells.
- Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple Myeloma: therapeutic implications.
- Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple Myeloma.
- CS1 promotes multiple Myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cells.
- Constitutive telomerase expression promotes mammary carcinomas in aging mice.
Schools
University Of Chile Faculty Of Med Sciences
Brigham and Women39s Hospital
Mass Gen Hospital
Conditions Treated
- Chronic Myeloid Leukemia (CML)
- Hodgkin's Disease
- Leukocytosis
- Myeloma
- View All
Doctors Specialties
- Hematology
- Hematopathology
- Pathology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
Massachusetts General Hospital -
University of Chile
Hospital
-
Brigham and Women's Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427150838 |
| Last Name Of The Provider | CARRASCO |
| First Name Of The Provider | RUBEN |
| View All |
Similar Doctors
|
|
Dr. Hart G. Lidov, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alanna J. Church, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas S. Micalizzi, MD |
|
|
Dr. Samuel G. Katz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Massimo F. Loda, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Anders H. Berg, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Elisabeth M. Battinelli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aric D. Parnes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Yee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kellie Sprague, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nora M. Laver, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Howard K. Koh, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Earl J. Kasdon, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|